Compare AU

Compare DRUG vs. GIVE

Compare shares and ETFs on the ASX that you can trade on Pearler.

BetaShares Global Healthcare ETF - Currency Hedged

ASX

Buy

Buy

Overview
Performance

Overview

When it comes to investing in the Australian stock market, shares and ETFs are a popular choice. Two options in the ASX are DRUG and GIVE. In this comparison, we'll delve into these options across various dimensions to help you make an informed investment decision.

Community Stats

DRUG

GIVE

Popularity

Low

Low

Pearlers invested

64

2

Median incremental investment

$990.50

$523.25

Median investment frequency

Monthly

Quarterly

Median total investment

$1,959.07

$810.00

Average age group

26 - 35

26 - 35


Key Summary

DRUG

GIVE

Strategy

DRUG.AX was created on 2016-08-04 by BetaShares. The fund's investment portfolio concentrates primarily on health care equity. DRUG.AX aims to track the performance of an index (before fees and expenses) that comprises the largest global healthcare companies (ex-Australia), hedged into Australian dollars.

GIVE.AX was created on 2021-11-29 by Perpetual. The fund's investment portfolio concentrates primarily on total market equity. Aims to: provide long-term capital growth and regular income through investment predominantly in quality Australian shares that meet Perpetuals ESG and values-based criteria outperform the S&P/ASX 300 Accumulation Index (before fees and taxes) over rolling three-year periods.

Top 3 holdings

CHF - SWISS FRANC (0 %)

AUD - AUSTRALIA DOLLAR (0 %)

DKK - DANISH KRONE (0 %)

Perpetual Esg Australian Share Fund (Managed Fund) (100 %)

Top 3 industries

Other (75.53 %)

Communication Services (33.53 %)

Health Care (24.47 %)

Top 3 countries

United States (71.71 %)

Switzerland (8.14 %)

Denmark (6.30 %)

Management fee

0.57 %

0.65 %


Key Summary

DRUG

GIVE

Issuer

BetaShares

Perpetual

Tracking index

Nasdaq Global ex-Australia Healthcare Hedged AUD Index - AUD

S&P/ASX 300 Index - AUD

Asset class

ETF

ETF

Management fee

0.57 %

0.65 %

Price

$8.36

$3.23

Size

$182.401 million

N/A

10Y return

N/A

N/A

Annual distribution/ dividend yield (5Y)

1.90 %

5.50 %

Market

ASX

ASX

First listed date

08/08/2016

28/11/2021

Purchase fee

$6.50

$6.50


Community Stats

DRUG

GIVE

Popularity

Low

Low

Pearlers invested

64

2

Median incremental investment

$990.50

$523.25

Median investment frequency

Monthly

Quarterly

Median total investment

$1,959.07

$810.00

Average age group

26 - 35

26 - 35


Pros and Cons

DRUG

GIVE

Pros

  • Higher exposure to US market

  • Lower management fee

  • Higher price growth

  • Higher distribution yield

Cons

  • Lower distribution yield

  • Lower exposure to US market

  • Higher management fee

  • Lower price growth

DRUG

GIVE

Higher exposure to US market

Lower exposure to US market

Lower management fee

Higher management fee

Higher price growth

Lower price growth

Lower distribution yield

Higher distribution yield

Home